2023 Regular Session • Rhode Island Legislature
S0098: Prescription Drug Cost Protection
Legislative Summary
Prohibits the state, ERISA or any health plans to purchase referenced drugs for a cost higher than the referenced rate.
Demographic Impact
Overall analysis of equity impact
90% Positive
High ConfidenceView detailed demographic breakdown ↓Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
Bill History
2/1/2023
Introduced, referred to Senate Health and Human Services
Senate
3/31/2023
Scheduled for hearing and/or consideration (04/04/2023)
Senate
4/4/2023
Committee recommended measure be held for further study
Senate
5/5/2023
Scheduled for hearing and/or consideration (05/09/2023)
Senate
5/9/2023
Committee recommended measure be held for further study
Senate
6/9/2023
Scheduled for consideration (06/13/2023)
Senate
6/12/2023
Proposed Substitute
Senate
6/13/2023
Committee recommends passage of Sub A
Senate
6/13/2023
Placed on Senate Calendar (06/14/2023)
Senate
6/14/2023
Senate passed Sub A
Senate
Roll Call Votes
Passage
6/14/2023
36
Yea
0
Nay
2
Not Voting
0
Absent
Result: PASSED
Status Information
Current Status
Engrossed(6/14/2023)
Chamber
House of Representatives
Sine DiePrior Session
Sponsors
Democrat: 6
Primary Sponsor
Louis Dipalma
Democrat